Doxil® - The first FDA-approved nano-drug: From an idea to a product

Yechezkel Chezy Barenholz*

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

37 Scopus citations

Fingerprint

Dive into the research topics of 'Doxil® - The first FDA-approved nano-drug: From an idea to a product'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Keyphrases